Role of T Cells in the Pathogenesis of Hodgkin's Disease (Q36752140)

16 August 2017

1 reference

title

Role of T cells in the pathogenesis of Hodgkin's disease (English)

1 reference

16 August 2017

Role of T Cells in the Pathogenesis of Hodgkin's Disease (English)

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

11 November 2022

1

E. Maggi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733870

11 November 2022

2

P. Parronchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733870

11 November 2022

D. Macchia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733870

11 November 2022

M. P. Piccinni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733870

11 November 2022

C. Simonelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733870

11 November 2022

S. Romagnani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1733870

11 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1733870

11 November 2022

publication date

1 January 1992

1 reference

International Review of Experimental Pathology

16 August 2017

published in

1 reference

16 August 2017

volume

33

1 reference

16 August 2017

page(s)

141-164

1 reference

Serum immunoglobulins G, A, M, D and E concentrations in lymphomas

16 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Lacunar cells of nodular sclerosing Hodgkin's disease:An ultrastructural and immunohistologic study

11 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Concanavalin A receptors on the surface membrane of lymphocytes from patient's with Hodgkin's disease and other malignant lymphomas

11 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Immunological family studies in Hodgkin's disease. Is the immunodeficiency horizontally transmitted?

11 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Lymphocytotoxic serum factors and lymphocyte functions in untreated Hodgkin's disease

11 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Circulating immune complexes in Hodgkin's disease

11 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients

11 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

11 November 2022

17

26

1290

Casazza

1966

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Serum migration-inhibitory activity in patients with lymphoproliferative diseases

11 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Hodgkin's disease at autopsy: 1972–1977

11 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Lymphocyte density distribution profile and spontaneous transformation related to the stage of Hodgkin's disease

11 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect

11 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Defective function of peripheral blood monocytes in patients with Hodgkin's and non-Hodgkin's lymphomas

11 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2

11 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease

11 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test

11 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Lymphocytes of Hodgkin's biopsies exhibit: stable E-rosette formation, natural attachment and glucocorticoid sensitivity, similar to immunoactivated T cells

11 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Herpes Zoster-Varicella infections and lymphoma

11 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Prostaglandin-Producing Suppressor Cells in Hodgkin's Disease

11 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency

11 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Clonal rearrangements of T-cell receptor and immunoglobulin genes and immunophenotypic antigen expression in different subclasses of Hodgkin's disease

11 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Impaired in Vitro Lymphocyte Transformation in Hodgkin's Disease

11 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity

11 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Common activated helper-T-cell origin for lymphomatoid papulosis, mycosis fungoides, and some types of Hodgkin's disease

11 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Hodgkin's disease: unfolding concepts concerning its nature, management and prognosis

11 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

"Sternberg-reed" giant cells of Hodgkin's Disease: cultivation in vitro, heterotransplantation, and characterization as neoplastic macrophages

11 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Increase of T lymphocytes in the spleen in Hodgkin's disease.

11 November 2022

52

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Immunoglobulin and T-cell receptor beta-chain gene rearrangement analysis of Hodgkin's disease: implications for lineage determination and differential diagnosis

11 November 2022

54

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Impaired monocyte-macrophage cytotoxicity in patients with Hodgkin's disease

11 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Cell-mediated immune deficiency in Hodgkin's disease

11 November 2022

56

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Antibodies to Epstein-Barr virus, cytomegalovirus, and Australia antigen in Hodgkin's disease

11 November 2022

57

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Decreased monocyte function in patients with Hodgkin's disease

11 November 2022

58

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Impaired lymphocyte function in untreated Hodgkin's disease.

11 November 2022

59

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

11 November 2022

60

36

3678

Lichtenfeld

1976

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Tissue culture studies in Hodgkin's disease morphologic, cytogenic, cell surface, and enzymatic properties of cultures derived from splenic tumors

11 November 2022

61

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

In Vitro Splenic IgG Synthesis in Hodgkin's Disease

11 November 2022

62

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Antibody-dependent lymphocytotoxicity induced by immunoglobulin G from Hodgkin's disease splenic lymphocytes

11 November 2022

63

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Profiles of lymphokine activities and helper function for IgE in human T cell clones

11 November 2022

65

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

CD4 + T Cells from Lymph Nodes Involved by Hodgkin's Disease Showing Response in Autologous Mixed Lymphocyte Reaction, are Polyclonal.

11 November 2022

67

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes

11 November 2022

68

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Family Distribution of Lymphocytotoxins in Hodgkin's Disease

11 November 2022

69

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Annual Review of Immunology

11 November 2022

71

7

135

Mossman

1989

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Infectious mononucleosis and Hodgkin's disease

11 November 2022

72

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells

11 November 2022

73

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Secondary malignant neoplasms in patients with Hodgkin's disease

11 November 2022

74

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Pathogenesis of Hodgkin's disease

11 November 2022

75

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production

11 November 2022

76

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease

11 November 2022

77

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Increased monocyte-mediated antibody-dependent cellular cytotoxicity (ADCC) in Hodgkin's disease

11 November 2022

78

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Serum factors inhibiting some leukocytic functions in Hodgkin's disease

11 November 2022

79

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Production of granulopoiesis-stimulating and -inhibiting activities by T cells associated with malignant cells in lymphomas

11 November 2022

80

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease

11 November 2022

81

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

The diversity of the immunohistological staining pattern of Sternberg-Reed cells

11 November 2022

83

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

The localization of Hodgkin's disease in lymph nodes. A study with immunohistological, enzyme histochemical and rosetting techniques on frozen sections

11 November 2022

85

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

11 November 2022

87

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

11 November 2022

88

34

2995

Rassiga-Pidot

1974

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

<i>In vitro</i> Lymphocyte Response to Phytomitogens in Untreated and Treated Patients with Hodgkin’s Disease

11 November 2022

91

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Study of some Immunological Parameters in Untreated Patients with Hodgkin’s Disease

11 November 2022

92

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Altered Proportion of Tmu and Tgamma-Cell Subpopulations in Patients with Hodgkin's Disease

11 November 2022

93

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Hyperproduction of IgE and T-cell dysfunction in Hodgkin's disease

11 November 2022

94

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Short- and long-term effects of radiation on T-cell subsets in peripheral blood of patients with Hodgkin's disease

11 November 2022

95

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Displacement of T lymphocytes with the 'Helper/Inducer' phenotype from peripheral blood to lymphoid organs in untreated patients with Hodgkin's disease

11 November 2022

97

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease

11 November 2022

98

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Anti-Ia reactivity in sera of untreated patients with active Hodgkin's disease

11 November 2022

99

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Human erythrocyte hexokinase deficiency: a new variant with abnormal kinetic properties

11 November 2022

100

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Clonal analysis of T lymphocytes in spleens from patients with Hodgkin's disease. Frequent occurrence of unusual T4-positive cells which co-express cytolytic activity and production of interleukin-2

11 November 2022

101

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

11 November 2022

104

48

37

Sanders

1988

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures

11 November 2022

105

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Two neoplastic cell lines with unique features derived from Hodgkin's disease

11 November 2022

108

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Inhibition of transformation of normal lymphocytes by plasma factor from patients with Hodgkin's disease and cancer.

11 November 2022

110

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells

11 November 2022

111

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Isolation of activated ras transforming genes from two patients with Hodgkin's disease

11 November 2022

112

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Hodgkin and sternberg-reed cells contain antigens specific to late cells of granulopoiesis

11 November 2022

115

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

The pathogenesis of Hodgkin's disease

11 November 2022

117

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Reactivity of HTLV-transformed human T-cell lines to MHC class II antigens.

11 November 2022

118

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Hodgkin's disease. An immunodepleting and immunosuppressive disorder

11 November 2022

120

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Spectrum of immunodeficiencies with Hodgkin's disease

11 November 2022

121

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Immunoglobulin gene rearrangements in Hodgkin's disease

11 November 2022

123

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

Impaired Humoral Immunity in Treated Hodgkin's Disease

11 November 2022

125

1 reference

https://api.crossref.org/works/10.1016/B978-0-12-364933-1.50011-4

11 November 2022

Identifiers

0 references

1 reference